XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balances at beginning at Dec. 31, 2022 $ 10,348 $ 8 $ 247,762 $ (237,422)  
Balances at beginning (shares) at Dec. 31, 2022   8,159,382      
Stock-based compensation 495   495    
Issuance of restricted stock units under equity incentive plans 136   136    
Issuance of restricted stock units under equity incentive plans (shares)   9,534      
Tax withholding payments for net share-settled equity awards (shares)   (128)      
Foreign currency translation adjustment 16       $ 16
Net loss (8,356)     (8,356)  
Balances at ending at Mar. 31, 2023 2,639 $ 8 248,393 (245,778) 16
Balances at end (shares) at Mar. 31, 2023   8,168,788      
Balances at beginning at Dec. 31, 2023 157,507 $ 32 433,885 (276,410)  
Balances at beginning (shares) at Dec. 31, 2023   31,678,159      
Stock-based compensation 6,445   6,445    
Issuance of restricted stock units under equity incentive plans (shares)   11,034      
Exercise of common stock warrants and pre-funded common stock warrants 923 $ 1 922    
Exercise of common stock warrants and pre-funded common stock warrants (shares)   1,644,886      
Exercise of stock options 15   15    
Exercise of stock options (shares)   3,000      
Unrealized loss on marketable securities (105)       (105)
Foreign currency translation adjustment (1)       (1)
Net loss (21,398)     (21,398)  
Balances at ending at Mar. 31, 2024 $ 143,386 $ 33 $ 441,267 $ (297,808) $ (106)
Balances at end (shares) at Mar. 31, 2024   33,337,079